Keywords: India, Pharmacovigilance, CDSCO, AIIMS, WHO

India’s national pharmacovigilance program to begin in April will open with several important drugs to come under review

Article | 19 March 2010

Among the drugs selected to kick of India’s national pharmacovigilance program, which starts in April, are two H1N1 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in